Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Dolutegravir and Its Combination Drug Market Size Growth Rate by Type (2014-2025) 1.4.2 Dolutegravir 1.4.3 Abacavir/Dolutegravir/Lamivudine 1.4.4 Dolutegravir/Rilpivirine 1.5 Market by Application 1.5.1 Global Dolutegravir and Its Combination Drug Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Drug Center 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Dolutegravir and Its Combination Drug Market Size 2.2 Dolutegravir and Its Combination Drug Growth Trends by Regions 2.2.1 Dolutegravir and Its Combination Drug Market Size by Regions (2014-2025) 2.2.2 Dolutegravir and Its Combination Drug Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Dolutegravir and Its Combination Drug Market Size by by Players 3.1.1 Global Dolutegravir and Its Combination Drug Revenue by by Players (2014-2019) 3.1.2 Global Dolutegravir and Its Combination Drug Revenue Market Share by by Players (2014-2019) 3.1.3 Global Dolutegravir and Its Combination Drug Market Concentration Ratio (CR5 and HHI) 3.2 Dolutegravir and Its Combination Drug Key Players Head office and Area Served 3.3 Key Players Dolutegravir and Its Combination Drug Product/Solution/Service 3.4 Date of Enter into Dolutegravir and Its Combination Drug Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) 4.2 Global Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) 5 United States 5.1 United States Dolutegravir and Its Combination Drug Market Size (2014-2019) 5.2 Dolutegravir and Its Combination Drug Key Players in United States 5.3 United States Dolutegravir and Its Combination Drug Market Size by Type 5.4 United States Dolutegravir and Its Combination Drug Market Size by Application 6 Europe 6.1 Europe Dolutegravir and Its Combination Drug Market Size (2014-2019) 6.2 Dolutegravir and Its Combination Drug Key Players in Europe 6.3 Europe Dolutegravir and Its Combination Drug Market Size by Type 6.4 Europe Dolutegravir and Its Combination Drug Market Size by Application 7 China 7.1 China Dolutegravir and Its Combination Drug Market Size (2014-2019) 7.2 Dolutegravir and Its Combination Drug Key Players in China 7.3 China Dolutegravir and Its Combination Drug Market Size by Type 7.4 China Dolutegravir and Its Combination Drug Market Size by Application 8 Japan 8.1 Japan Dolutegravir and Its Combination Drug Market Size (2014-2019) 8.2 Dolutegravir and Its Combination Drug Key Players in Japan 8.3 Japan Dolutegravir and Its Combination Drug Market Size by Type 8.4 Japan Dolutegravir and Its Combination Drug Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Dolutegravir and Its Combination Drug Market Size (2014-2019) 9.2 Dolutegravir and Its Combination Drug Key Players in Southeast Asia 9.3 Southeast Asia Dolutegravir and Its Combination Drug Market Size by Type 9.4 Southeast Asia Dolutegravir and Its Combination Drug Market Size by Application 10 India 10.1 India Dolutegravir and Its Combination Drug Market Size (2014-2019) 10.2 Dolutegravir and Its Combination Drug Key Players in India 10.3 India Dolutegravir and Its Combination Drug Market Size by Type 10.4 India Dolutegravir and Its Combination Drug Market Size by Application 11 Central & South America 11.1 Central & South America Dolutegravir and Its Combination Drug Market Size (2014-2019) 11.2 Dolutegravir and Its Combination Drug Key Players in Central & South America 11.3 Central & South America Dolutegravir and Its Combination Drug Market Size by Type 11.4 Central & South America Dolutegravir and Its Combination Drug Market Size by Application 12 International Players Profiles 12.1 ViiV Healthcare (GSK) 12.1.1 ViiV Healthcare (GSK) Company Details 12.1.2 Company Description and Business Overview 12.1.3 Dolutegravir and Its Combination Drug Introduction 12.1.4 ViiV Healthcare (GSK) Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.1.5 ViiV Healthcare (GSK) Recent Development 12.2 Adcock Ingram Limited 12.2.1 Adcock Ingram Limited Company Details 12.2.2 Company Description and Business Overview 12.2.3 Dolutegravir and Its Combination Drug Introduction 12.2.4 Adcock Ingram Limited Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.2.5 Adcock Ingram Limited Recent Development 12.3 Aurobindo Pharma 12.3.1 Aurobindo Pharma Company Details 12.3.2 Company Description and Business Overview 12.3.3 Dolutegravir and Its Combination Drug Introduction 12.3.4 Aurobindo Pharma Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.3.5 Aurobindo Pharma Recent Development 12.4 Cipla 12.4.1 Cipla Company Details 12.4.2 Company Description and Business Overview 12.4.3 Dolutegravir and Its Combination Drug Introduction 12.4.4 Cipla Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.4.5 Cipla Recent Development 12.5 Emcure Pharmaceuticals 12.5.1 Emcure Pharmaceuticals Company Details 12.5.2 Company Description and Business Overview 12.5.3 Dolutegravir and Its Combination Drug Introduction 12.5.4 Emcure Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.5.5 Emcure Pharmaceuticals Recent Development 12.6 LAURUS Labs 12.6.1 LAURUS Labs Company Details 12.6.2 Company Description and Business Overview 12.6.3 Dolutegravir and Its Combination Drug Introduction 12.6.4 LAURUS Labs Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.6.5 LAURUS Labs Recent Development 12.7 Mylan 12.7.1 Mylan Company Details 12.7.2 Company Description and Business Overview 12.7.3 Dolutegravir and Its Combination Drug Introduction 12.7.4 Mylan Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.7.5 Mylan Recent Development 12.8 Ranbaxy Pharmaceuticals 12.8.1 Ranbaxy Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Dolutegravir and Its Combination Drug Introduction 12.8.4 Ranbaxy Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.8.5 Ranbaxy Pharmaceuticals Recent Development 12.9 Shanghai Desano Pharmaceuticals 12.9.1 Shanghai Desano Pharmaceuticals Company Details 12.9.2 Company Description and Business Overview 12.9.3 Dolutegravir and Its Combination Drug Introduction 12.9.4 Shanghai Desano Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.9.5 Shanghai Desano Pharmaceuticals Recent Development 12.10 JNJ 12.10.1 JNJ Company Details 12.10.2 Company Description and Business Overview 12.10.3 Dolutegravir and Its Combination Drug Introduction 12.10.4 JNJ Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) 12.10.5 JNJ Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Dolutegravir and Its Combination Drug Key Market Segments Table Key Players Dolutegravir and Its Combination Drug Covered Table Global Dolutegravir and Its Combination Drug Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global Dolutegravir and Its Combination Drug Market Share by TypeType in 2018 & 2025 Figure Dolutegravir Figures Table Key Players of Dolutegravir Figure Abacavir/Dolutegravir/Lamivudine Figures Table Key Players of Abacavir/Dolutegravir/Lamivudine Figure Dolutegravir/Rilpivirine Figures Table Key Players of Dolutegravir/Rilpivirine Table Global Dolutegravir and Its Combination Drug Market Size Growth by Application 2019-2025 (Million US$) Figure Global Dolutegravir and Its Combination Drug Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinic Case Studies Figure Drug Center Case Studies Figure Other Case Studies Figure Dolutegravir and Its Combination Drug Report Years Considered Table Global Dolutegravir and Its Combination Drug Market Size 2014-2025 (Million US$) Figure Global Dolutegravir and Its Combination Drug Market Size and Growth Rate 2014-2025 (Million US$) Table Global Dolutegravir and Its Combination Drug Market Size by Regions 2019-2025 (Million US$) Table Global Dolutegravir and Its Combination Drug Market Size by Regions 2019-2025 (Million US$) Table Global Dolutegravir and Its Combination Drug Market Share by Regions 2014-2019 Figure Global Dolutegravir and Its Combination Drug Market Share by Regions 2014-2019 Figure Global Dolutegravir and Its Combination Drug Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Dolutegravir and Its Combination Drug Revenue by by Players (2014-2019) (Million US$) Table Global Dolutegravir and Its Combination Drug Market Share by by Players (2014-2019) Figure Global Dolutegravir and Its Combination Drug Market Share by by Players in 2018 Table Global Dolutegravir and Its Combination Drug by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Dolutegravir and Its Combination Drug Product/Solution/Service Table Date of Enter into Dolutegravir and Its Combination Drug Market Table Mergers & Acquisitions, Expansion Plans Table Global Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table Global Dolutegravir and Its Combination Drug Market Size Share by Type (2014-2019) Figure Global Dolutegravir and Its Combination Drug Market Size Market Share by Type (2014-2019) Table Global Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table Global Dolutegravir and Its Combination Drug Market Size Share by Application (2014-2019) Figure Global Dolutegravir and Its Combination Drug Market Size Market Share by Application (2014-2019) Figure Global Dolutegravir and Its Combination Drug Revenue Market Share by Application in 2018 Figure United States Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table United States Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table United States Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table United States Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table United States Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table United States Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table United States Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure Europe Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table Europe Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table Europe Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table Europe Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table Europe Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table Europe Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table Europe Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure China Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table China Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table China Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table China Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table China Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table China Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table China Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure Japan Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table Japan Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table Japan Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table Japan Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table Japan Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table Japan Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table Japan Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure Southeast Asia Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table Southeast Asia Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table Southeast Asia Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure India Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table India Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table India Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table India Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table India Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table India Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table India Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Figure Central & South America Dolutegravir and Its Combination Drug Market Size 2014-2019 (Million US$) Table Central & South America Key Players Dolutegravir and Its Combination Drug Revenue (2018-2019) (Million US$) Table Central & South America Key Players Dolutegravir and Its Combination Drug Market Share (2018-2019) Table Central & South America Dolutegravir and Its Combination Drug Market Size by Type (2014-2019) (Million US$) Table Central & South America Dolutegravir and Its Combination Drug Market Share by Type (2014-2019) Table Central & South America Dolutegravir and Its Combination Drug Market Size by Application (2014-2019) (Million US$) Table Central & South America Dolutegravir and Its Combination Drug Market Share by Application (2014-2019) Table ViiV Healthcare (GSK) Company Details Table ViiV Healthcare (GSK) Revenue in Dolutegravir and Its Combination Drug Business (2014-2019) (Million US$) Figure ViiV Healthcare (GSK) Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table ViiV Healthcare (GSK) Recent Development Table Adcock Ingram Limited Company Details Table Adcock Ingram Limited Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Adcock Ingram Limited Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Adcock Ingram Limited Recent Development Table Aurobindo Pharma Company Details Table Aurobindo Pharma Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Aurobindo Pharma Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Aurobindo Pharma Recent Development Table Cipla Company Details Table Cipla Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Cipla Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Cipla Recent Development Table Emcure Pharmaceuticals Company Details Table Emcure Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Emcure Pharmaceuticals Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Emcure Pharmaceuticals Recent Development Table LAURUS Labs Company Details Table LAURUS Labs Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure LAURUS Labs Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table LAURUS Labs Recent Development Table Mylan Company Details Table Mylan Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Mylan Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Mylan Recent Development Table Ranbaxy Pharmaceuticals Company Details Table Ranbaxy Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Ranbaxy Pharmaceuticals Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Ranbaxy Pharmaceuticals Recent Development Table Shanghai Desano Pharmaceuticals Company Details Table Shanghai Desano Pharmaceuticals Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure Shanghai Desano Pharmaceuticals Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table Shanghai Desano Pharmaceuticals Recent Development Table JNJ Company Details Table JNJ Revenue in Dolutegravir and Its Combination Drug Business (2014-2019)(Million US$) Figure JNJ Revenue Growth Rate in Dolutegravir and Its Combination Drug Business (2014-2019) Table JNJ Recent Development Table Global Dolutegravir and Its Combination Drug Market Size by Regions (Million US$) 2019-2025 Figure Global Dolutegravir and Its Combination Drug Market Size Share by Regions (2019-2025) Figure Global Dolutegravir and Its Combination Drug Market Size Share by Regions in 2025 Figure United States Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure Europe Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure China Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure Japan Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure India Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Dolutegravir and Its Combination Drug Market Size Forecast (2019-2025)(Million USD) Table Global Dolutegravir and Its Combination Drug Market Size by Product (2019-2025) (Million US$) Figure Global Dolutegravir and Its Combination Drug Market Size by Product (2019-2025) Figure Global Dolutegravir and Its Combination Drug Market Size by Product in 2025 Table Global Dolutegravir and Its Combination Drug Market Size by Application (2019-2025) (Million US$) Figure Global Dolutegravir and Its Combination Drug Market Size by Application (2019-2025) Figure Global Dolutegravir and Its Combination Drug Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

ViiV Healthcare (GSK) Adcock Ingram Limited Aurobindo Pharma Cipla Emcure Pharmaceuticals LAURUS Labs Mylan Ranbaxy Pharmaceuticals Shanghai Desano Pharmaceuticals JNJ